Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

The science of contemporary street protest: New efforts in the United States.

Fisher DR, Andrews KT, Caren N, Chenoweth E, Heaney MT, Leung T, Perkins LN, Pressman J.

Sci Adv. 2019 Oct 23;5(10):eaaw5461. doi: 10.1126/sciadv.aaw5461. eCollection 2019 Oct. Review.

2.

Cyclization-blocked proguanil as a strategy to improve the antimalarial activity of atovaquone.

Skinner-Adams TS, Fisher GM, Riches AG, Hutt OE, Jarvis KE, Wilson T, von Itzstein M, Chopra P, Antonova-Koch Y, Meister S, Winzeler EA, Clarke M, Fidock DA, Burrows JN, Ryan JH, Andrews KT.

Commun Biol. 2019 May 3;2:166. doi: 10.1038/s42003-019-0397-3. eCollection 2019.

3.

Proteomic analysis of Plasmodium falciparum histone deacetylase 1 complex proteins.

Engel JA, Norris EL, Gilson P, Przyborski J, Shonhai A, Blatch GL, Skinner-Adams TS, Gorman J, Headlam M, Andrews KT.

Exp Parasitol. 2019 Mar;198:7-16. doi: 10.1016/j.exppara.2019.01.008. Epub 2019 Jan 22.

PMID:
30682336
4.

Structure-Activity and Structure-Toxicity Relationships of Peptoid-Based Histone Deacetylase Inhibitors with Dual-Stage Antiplasmodial Activity.

Mackwitz MKW, Hesping E, Antonova-Koch Y, Diedrich D, Woldearegai TG, Skinner-Adams T, Clarke M, Schöler A, Limbach L, Kurz T, Winzeler EA, Held J, Andrews KT, Hansen FK.

ChemMedChem. 2019 May 6;14(9):912-926. doi: 10.1002/cmdc.201800808. Epub 2019 Feb 19.

PMID:
30664827
5.

Identification of novel quinazoline derivatives as potent antiplasmodial agents.

Bouchut A, Rotili D, Pierrot C, Valente S, Lafitte S, Schultz J, Hoglund U, Mazzone R, Lucidi A, Fabrizi G, Pechalrieu D, Arimondo PB, Skinner-Adams TS, Chua MJ, Andrews KT, Mai A, Khalife J.

Eur J Med Chem. 2019 Jan 1;161:277-291. doi: 10.1016/j.ejmech.2018.10.041. Epub 2018 Oct 17.

PMID:
30366254
6.

One-pot, multi-component synthesis and structure-activity relationships of peptoid-based histone deacetylase (HDAC) inhibitors targeting malaria parasites.

Diedrich D, Stenzel K, Hesping E, Antonova-Koch Y, Gebru T, Duffy S, Fisher G, Schöler A, Meister S, Kurz T, Avery VM, Winzeler EA, Held J, Andrews KT, Hansen FK.

Eur J Med Chem. 2018 Oct 5;158:801-813. doi: 10.1016/j.ejmech.2018.09.018. Epub 2018 Sep 7.

7.

Correction to Catalyst-Controlled Stereoselective Synthesis Secures the Structure of the Antimalarial Isocyanoterpene Pustulosaisonitrile-1.

White AM, Dao K, Vrubliauskas D, Konst ZA, Pierens GK, Mándi A, Andrews KT, Skinner-Adams TS, Clarke ME, Narbutas PT, Sim DC, Cheney KL, Kurtán T, Garson MJ, Vanderwal CD.

J Org Chem. 2018 Aug 17;83(16):9571-9572. doi: 10.1021/acs.joc.8b01819. Epub 2018 Jul 31. No abstract available.

PMID:
30062886
8.

Activity of bromodomain protein inhibitors/binders against asexual-stage Plasmodium falciparum parasites.

Chua MJ, Robaa D, Skinner-Adams TS, Sippl W, Andrews KT.

Int J Parasitol Drugs Drug Resist. 2018 Aug;8(2):189-193. doi: 10.1016/j.ijpddr.2018.03.001. Epub 2018 Mar 26.

9.

Rapid loss of group 1 innate lymphoid cells during blood stage Plasmodium infection.

Ng SS, Souza-Fonseca-Guimaraes F, Rivera FL, Amante FH, Kumar R, Gao Y, Sheel M, Beattie L, Montes de Oca M, Guillerey C, Edwards CL, Faleiro RJ, Frame T, Bunn PT, Vivier E, Godfrey DI, Pellicci DG, Lopez JA, Andrews KT, Huntington ND, Smyth MJ, McCarthy J, Engwerda CR.

Clin Transl Immunology. 2018 Jan 12;7(1):e1003. doi: 10.1002/cti2.1003. eCollection 2018.

10.

Fragment-Based Screening of a Natural Product Library against 62 Potential Malaria Drug Targets Employing Native Mass Spectrometry.

Vu H, Pedro L, Mak T, McCormick B, Rowley J, Liu M, Di Capua A, Williams-Noonan B, Pham NB, Pouwer R, Nguyen B, Andrews KT, Skinner-Adams T, Kim J, Hol WGJ, Hui R, Crowther GJ, Van Voorhis WC, Quinn RJ.

ACS Infect Dis. 2018 Apr 13;4(4):431-444. doi: 10.1021/acsinfecdis.7b00197. Epub 2018 Mar 3.

11.

Catalyst-Controlled Stereoselective Synthesis Secures the Structure of the Antimalarial Isocyanoterpene Pustulosaisonitrile-1.

White AM, Dao K, Vrubliauskas D, Könst ZA, Pierens GK, Mándi A, Andrews KT, Skinner-Adams TS, Clarke ME, Narbutas PT, Sim DC, Cheney KL, Kurtán T, Garson MJ, Vanderwal CD.

J Org Chem. 2017 Dec 15;82(24):13313-13323. doi: 10.1021/acs.joc.7b02421. Epub 2017 Nov 28. Erratum in: J Org Chem. 2018 Aug 17;83(16):9571-9572.

PMID:
29124922
12.

Design and Synthesis of Terephthalic Acid-Based Histone Deacetylase Inhibitors with Dual-Stage Anti-Plasmodium Activity.

Stenzel K, Chua MJ, Duffy S, Antonova-Koch Y, Meister S, Hamacher A, Kassack MU, Winzeler E, Avery VM, Kurz T, Andrews KT, Hansen FK.

ChemMedChem. 2017 Oct 9;12(19):1627-1636. doi: 10.1002/cmdc.201700360. Epub 2017 Sep 13.

PMID:
28812327
13.

Deguelin exerts potent nematocidal activity via the mitochondrial respiratory chain.

Preston S, Korhonen PK, Mouchiroud L, Cornaglia M, McGee SL, Young ND, Davis RA, Crawford S, Nowell C, Ansell BRE, Fisher GM, Andrews KT, Chang BCH, Gijs MAM, Sternberg PW, Auwerx J, Baell J, Hofmann A, Jabbar A, Gasser RB.

FASEB J. 2017 Oct;31(10):4515-4532. doi: 10.1096/fj.201700288R. Epub 2017 Jul 7.

PMID:
28687609
14.

Assessing the anthelmintic activity of pyrazole-5-carboxamide derivatives against Haemonchus contortus.

Jiao Y, Preston S, Song H, Jabbar A, Liu Y, Baell J, Hofmann A, Hutchinson D, Wang T, Koehler AV, Fisher GM, Andrews KT, Laleu B, Palmer MJ, Burrows JN, Wells TNC, Wang Q, Gasser RB.

Parasit Vectors. 2017 May 31;10(1):272. doi: 10.1186/s13071-017-2191-8.

15.

Design and Synthesis of Novel Anti-Plasmodial Histone Deacetylase Inhibitors Containing an Alkoxyamide Connecting Unit.

Alves Avelar LA, Held J, Engel JA, Sureechatchaiyan P, Hansen FK, Hamacher A, Kassack MU, Mordmüller B, Andrews KT, Kurz T.

Arch Pharm (Weinheim). 2017 Apr;350(3-4). doi: 10.1002/ardp.201600347. Epub 2017 Mar 20.

PMID:
28317157
16.

A novel in vitro image-based assay identifies new drug leads for giardiasis.

Hart CJ, Munro T, Andrews KT, Ryan JH, Riches AG, Skinner-Adams TS.

Int J Parasitol Drugs Drug Resist. 2017 Apr;7(1):83-89. doi: 10.1016/j.ijpddr.2017.01.005. Epub 2017 Jan 27.

17.

Investigating the antiplasmodial activity of primary sulfonamide compounds identified in open source malaria data.

Fisher GM, Bua S, Del Prete S, Arnold MS, Capasso C, Supuran CT, Andrews KT, Poulsen SA.

Int J Parasitol Drugs Drug Resist. 2017 Apr;7(1):61-70. doi: 10.1016/j.ijpddr.2017.01.003. Epub 2017 Jan 13.

18.

Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth.

Chua MJ, Arnold MS, Xu W, Lancelot J, Lamotte S, Späth GF, Prina E, Pierce RJ, Fairlie DP, Skinner-Adams TS, Andrews KT.

Int J Parasitol Drugs Drug Resist. 2017 Apr;7(1):42-50. doi: 10.1016/j.ijpddr.2016.12.005. Epub 2016 Dec 23.

19.

Synthesis, biological characterisation and structure activity relationships of aromatic bisamidines active against Plasmodium falciparum.

Sauer B, Skinner-Adams TS, Bouchut A, Chua MJ, Pierrot C, Erdmann F, Robaa D, Schmidt M, Khalife J, Andrews KT, Sippl W.

Eur J Med Chem. 2017 Feb 15;127:22-40. doi: 10.1016/j.ejmech.2016.12.041. Epub 2016 Dec 23.

PMID:
28038325
20.

Erratum to "Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites" [Int. J. Parasitol. Drugs Drug Res. 5 (2015) 117-126].

Engel JA, Jones AJ, Avery VM, Sumanadasa SDM, Ng SS, Fairlie DP, Skinner-Adams T, Andrews KT.

Int J Parasitol Drugs Drug Resist. 2016 Dec;6(3):287. doi: 10.1016/j.ijpddr.2016.05.001. Epub 2016 May 30. No abstract available.

21.

Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond.

Van Voorhis WC, Adams JH, Adelfio R, Ahyong V, Akabas MH, Alano P, Alday A, Alemán Resto Y, Alsibaee A, Alzualde A, Andrews KT, Avery SV, Avery VM, Ayong L, Baker M, Baker S, Ben Mamoun C, Bhatia S, Bickle Q, Bounaadja L, Bowling T, Bosch J, Boucher LE, Boyom FF, Brea J, Brennan M, Burton A, Caffrey CR, Camarda G, Carrasquilla M, Carter D, Belen Cassera M, Chih-Chien Cheng K, Chindaudomsate W, Chubb A, Colon BL, Colón-López DD, Corbett Y, Crowther GJ, Cowan N, D'Alessandro S, Le Dang N, Delves M, DeRisi JL, Du AY, Duffy S, Abd El-Salam El-Sayed S, Ferdig MT, Fernández Robledo JA, Fidock DA, Florent I, Fokou PV, Galstian A, Gamo FJ, Gokool S, Gold B, Golub T, Goldgof GM, Guha R, Guiguemde WA, Gural N, Guy RK, Hansen MA, Hanson KK, Hemphill A, Hooft van Huijsduijnen R, Horii T, Horrocks P, Hughes TB, Huston C, Igarashi I, Ingram-Sieber K, Itoe MA, Jadhav A, Naranuntarat Jensen A, Jensen LT, Jiang RH, Kaiser A, Keiser J, Ketas T, Kicka S, Kim S, Kirk K, Kumar VP, Kyle DE, Lafuente MJ, Landfear S, Lee N, Lee S, Lehane AM, Li F, Little D, Liu L, Llinás M, Loza MI, Lubar A, Lucantoni L, Lucet I, Maes L, Mancama D, Mansour NR, March S, McGowan S, Medina Vera I, Meister S, Mercer L, Mestres J, Mfopa AN, Misra RN, Moon S, Moore JP, Morais Rodrigues da Costa F, Müller J, Muriana A, Nakazawa Hewitt S, Nare B, Nathan C, Narraidoo N, Nawaratna S, Ojo KK, Ortiz D, Panic G, Papadatos G, Parapini S, Patra K, Pham N, Prats S, Plouffe DM, Poulsen SA, Pradhan A, Quevedo C, Quinn RJ, Rice CA, Abdo Rizk M, Ruecker A, St Onge R, Salgado Ferreira R, Samra J, Robinett NG, Schlecht U, Schmitt M, Silva Villela F, Silvestrini F, Sinden R, Smith DA, Soldati T, Spitzmüller A, Stamm SM, Sullivan DJ, Sullivan W, Suresh S, Suzuki BM, Suzuki Y, Swamidass SJ, Taramelli D, Tchokouaha LR, Theron A, Thomas D, Tonissen KF, Townson S, Tripathi AK, Trofimov V, Udenze KO, Ullah I, Vallieres C, Vigil E, Vinetz JM, Voong Vinh P, Vu H, Watanabe NA, Weatherby K, White PM, Wilks AF, Winzeler EA, Wojcik E, Wree M, Wu W, Yokoyama N, Zollo PH, Abla N, Blasco B, Burrows J, Laleu B, Leroy D, Spangenberg T, Wells T, Willis PA.

PLoS Pathog. 2016 Jul 28;12(7):e1005763. doi: 10.1371/journal.ppat.1005763. eCollection 2016 Jul.

22.

Adaptation of the [3H]Hypoxanthine Uptake Assay for In Vitro-Cultured Plasmodium knowlesi Malaria Parasites.

Arnold MS, Engel JA, Chua MJ, Fisher GM, Skinner-Adams TS, Andrews KT.

Antimicrob Agents Chemother. 2016 Jun 20;60(7):4361-3. doi: 10.1128/AAC.02948-15. Print 2016 Jul.

23.

Defining the targets of antiparasitic compounds.

Skinner-Adams TS, Sumanadasa SD, Fisher GM, Davis RA, Doolan DL, Andrews KT.

Drug Discov Today. 2016 May;21(5):725-39. doi: 10.1016/j.drudis.2016.01.002. Epub 2016 Jan 16. Review.

PMID:
26784142
24.
25.

Synthesis and Antiplasmodial Evaluation of Analogues Based on the Tricyclic Core of Thiaplakortones A-D.

Schwartz BD, Coster MJ, Skinner-Adams TS, Andrews KT, White JM, Davis RA.

Mar Drugs. 2015 Sep 15;13(9):5784-95. doi: 10.3390/md13095784.

26.

Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites.

Engel JA, Jones AJ, Avery VM, Sumanadasa SD, Ng SS, Fairlie DP, Skinner-Adams T, Andrews KT.

Int J Parasitol Drugs Drug Resist. 2015 Jun 20;5(3):117-26. doi: 10.1016/j.ijpddr.2015.05.004. eCollection 2015 Dec. Erratum in: Int J Parasitol Drugs Drug Resist. 2016 Dec;6(3):287. Adams, Tina S [corrected to Skinner-Adams, Tina].

27.

Entonalactams A-C: Isoindolinone derivatives from an Australian rainforest fungus belonging to the genus Entonaema.

Choomuenwai V, Beattie KD, Healy PC, Andrews KT, Fechner N, Davis RA.

Phytochemistry. 2015 Sep;117:10-16. doi: 10.1016/j.phytochem.2015.05.018. Epub 2015 Jun 5.

PMID:
26057224
28.

Antimalarial Isocyano and Isothiocyanato Sesquiterpenes with Tri- and Bicyclic Skeletons from the Nudibranch Phyllidia ocellata.

White AM, Pierens GK, Skinner-Adams T, Andrews KT, Bernhardt PV, Krenske EH, Mollo E, Garson MJ.

J Nat Prod. 2015 Jun 26;78(6):1422-7. doi: 10.1021/acs.jnatprod.5b00354. Epub 2015 Jun 9.

PMID:
26056748
29.

Sulfonamide inhibition studies of the η-class carbonic anhydrase from the malaria pathogen Plasmodium falciparum.

Vullo D, Del Prete S, Fisher GM, Andrews KT, Poulsen SA, Capasso C, Supuran CT.

Bioorg Med Chem. 2015 Feb 1;23(3):526-31. doi: 10.1016/j.bmc.2014.12.009. Epub 2014 Dec 11.

PMID:
25533402
30.

Synthesis and antimalarial evaluation of amide and urea derivatives based on the thiaplakortone A natural product scaffold.

Schwartz BD, Skinner-Adams TS, Andrews KT, Coster MJ, Edstein MD, MacKenzie D, Charman SA, Koltun M, Blundell S, Campbell A, Pouwer RH, Quinn RJ, Beattie KD, Healy PC, Davis RA.

Org Biomol Chem. 2015 Feb 7;13(5):1558-70. doi: 10.1039/c4ob01849d.

PMID:
25490858
31.

Discovery of a new family of carbonic anhydrases in the malaria pathogen Plasmodium falciparum--the η-carbonic anhydrases.

Del Prete S, Vullo D, Fisher GM, Andrews KT, Poulsen SA, Capasso C, Supuran CT.

Bioorg Med Chem Lett. 2014 Sep 15;24(18):4389-4396. doi: 10.1016/j.bmcl.2014.08.015. Epub 2014 Aug 12.

PMID:
25168745
32.

Drug repurposing and human parasitic protozoan diseases.

Andrews KT, Fisher G, Skinner-Adams TS.

Int J Parasitol Drugs Drug Resist. 2014 Mar 24;4(2):95-111. doi: 10.1016/j.ijpddr.2014.02.002. eCollection 2014 Aug. Review.

33.

Discovery of HDAC inhibitors with potent activity against multiple malaria parasite life cycle stages.

Hansen FK, Sumanadasa SD, Stenzel K, Duffy S, Meister S, Marek L, Schmetter R, Kuna K, Hamacher A, Mordmüller B, Kassack MU, Winzeler EA, Avery VM, Andrews KT, Kurz T.

Eur J Med Chem. 2014 Jul 23;82:204-13. doi: 10.1016/j.ejmech.2014.05.050. Epub 2014 May 22.

34.

Total synthesis of thiaplakortone a: derivatives as metabolically stable leads for the treatment of malaria.

Pouwer RH, Deydier SM, Le PV, Schwartz BD, Franken NC, Davis RA, Coster MJ, Charman SA, Edstein MD, Skinner-Adams TS, Andrews KT, Jenkins ID, Quinn RJ.

ACS Med Chem Lett. 2013 Dec 27;5(2):178-82. doi: 10.1021/ml400447v. eCollection 2014 Feb 13.

35.

Lysine acetylation in sexual stage malaria parasites is a target for antimalarial small molecules.

Trenholme K, Marek L, Duffy S, Pradel G, Fisher G, Hansen FK, Skinner-Adams TS, Butterworth A, Ngwa CJ, Moecking J, Goodman CD, McFadden GI, Sumanadasa SD, Fairlie DP, Avery VM, Kurz T, Andrews KT.

Antimicrob Agents Chemother. 2014 Jul;58(7):3666-78. doi: 10.1128/AAC.02721-13. Epub 2014 Apr 14.

36.

Synthesis and evaluation of antimalarial properties of novel 4-aminoquinoline hybrid compounds.

Fisher GM, Tanpure RP, Douchez A, Andrews KT, Poulsen SA.

Chem Biol Drug Des. 2014 Oct;84(4):462-72. doi: 10.1111/cbdd.12335. Epub 2014 Jun 3.

PMID:
24720445
37.

Synthesis, antimalarial properties, and SAR studies of alkoxyurea-based HDAC inhibitors.

Hansen FK, Skinner-Adams TS, Duffy S, Marek L, Sumanadasa SD, Kuna K, Held J, Avery VM, Andrews KT, Kurz T.

ChemMedChem. 2014 Mar;9(3):665-70. doi: 10.1002/cmdc.201300469. Epub 2014 Feb 4.

PMID:
24497437
38.

Antimalarial activity of compounds comprising a primary benzene sulfonamide fragment.

Andrews KT, Fisher GM, Sumanadasa SD, Skinner-Adams T, Moeker J, Lopez M, Poulsen SA.

Bioorg Med Chem Lett. 2013 Nov 15;23(22):6114-7. doi: 10.1016/j.bmcl.2013.09.015. Epub 2013 Sep 14.

PMID:
24084158
39.

Plasmodium gametocyte inhibition identified from a natural-product-based fragment library.

Vu H, Roullier C, Campitelli M, Trenholme KR, Gardiner DL, Andrews KT, Skinner-Adams T, Crowther GJ, Van Voorhis WC, Quinn RJ.

ACS Chem Biol. 2013 Dec 20;8(12):2654-9. doi: 10.1021/cb400582b. Epub 2013 Oct 3.

PMID:
24079418
40.

Chemical investigation of an antimalarial Chinese medicinal herb Picrorhiza scrophulariiflora.

Wang H, Zhao W, Choomuenwai V, Andrews KT, Quinn RJ, Feng Y.

Bioorg Med Chem Lett. 2013 Nov 1;23(21):5915-8. doi: 10.1016/j.bmcl.2013.08.077. Epub 2013 Aug 27.

41.

Psammaplysin derivatives from the Balinese marine sponge Aplysinella strongylata.

Mudianta IW, Skinner-Adams T, Andrews KT, Davis RA, Hadi TA, Hayes PY, Garson MJ.

J Nat Prod. 2012 Dec 28;75(12):2132-43. doi: 10.1021/np300560b. Epub 2012 Dec 6.

PMID:
23215158
42.

Synthesis and antimalarial evaluation of a screening library based on a tetrahydroanthraquinone natural product scaffold.

Choomuenwai V, Andrews KT, Davis RA.

Bioorg Med Chem. 2012 Dec 15;20(24):7167-74. doi: 10.1016/j.bmc.2012.09.052. Epub 2012 Oct 10.

PMID:
23117170
43.

Antimalarial activity of pyrroloiminoquinones from the Australian marine sponge Zyzzya sp.

Davis RA, Buchanan MS, Duffy S, Avery VM, Charman SA, Charman WN, White KL, Shackleford DM, Edstein MD, Andrews KT, Camp D, Quinn RJ.

J Med Chem. 2012 Jun 28;55(12):5851-8. doi: 10.1021/jm3002795. Epub 2012 Jun 20.

PMID:
22686608
44.

Towards histone deacetylase inhibitors as new antimalarial drugs.

Andrews KT, Tran TN, Fairlie DP.

Curr Pharm Des. 2012;18(24):3467-79. Review.

PMID:
22607140
45.

Antimalarial activity of the anticancer histone deacetylase inhibitor SB939.

Sumanadasa SD, Goodman CD, Lucke AJ, Skinner-Adams T, Sahama I, Haque A, Do TA, McFadden GI, Fairlie DP, Andrews KT.

Antimicrob Agents Chemother. 2012 Jul;56(7):3849-56. doi: 10.1128/AAC.00030-12. Epub 2012 Apr 16.

46.

Design and synthesis of screening libraries based on the muurolane natural product scaffold.

Barnes EC, Choomuenwai V, Andrews KT, Quinn RJ, Davis RA.

Org Biomol Chem. 2012 May 28;10(20):4015-23. doi: 10.1039/c2ob00029f. Epub 2012 Mar 15.

PMID:
22422350
47.

Comparative gene expression profiling of P. falciparum malaria parasites exposed to three different histone deacetylase inhibitors.

Andrews KT, Gupta AP, Tran TN, Fairlie DP, Gobert GN, Bozdech Z.

PLoS One. 2012;7(2):e31847. doi: 10.1371/journal.pone.0031847. Epub 2012 Feb 27.

48.

HDAC inhibitors in parasitic diseases.

Andrews KT, Haque A, Jones MK.

Immunol Cell Biol. 2012 Jan;90(1):66-77. doi: 10.1038/icb.2011.97. Epub 2011 Nov 29. Review.

PMID:
22124373
49.

Synthesis and antimalarial evaluation of novel benzopyrano[4,3-b]benzopyran derivatives.

Devakaram R, Black DS, Andrews KT, Fisher GM, Davis RA, Kumar N.

Bioorg Med Chem. 2011 Sep 1;19(17):5199-206. doi: 10.1016/j.bmc.2011.07.009. Epub 2011 Jul 23.

PMID:
21824783
50.

Psammaplysin H, a new antimalarial bromotyrosine alkaloid from a marine sponge of the genus Pseudoceratina.

Xu M, Andrews KT, Birrell GW, Tran TL, Camp D, Davis RA, Quinn RJ.

Bioorg Med Chem Lett. 2011 Jan 15;21(2):846-8. doi: 10.1016/j.bmcl.2010.11.081. Epub 2010 Nov 21.

PMID:
21190857

Supplemental Content

Loading ...
Support Center